| Day 1 | Hall A | ||||
|
9-9.45 AM |
Plenary 1 |
||||
|
9.45- 10.30 AM |
Oration | ||||
|
10.30- 11AM |
Coffee |
||||
| Hall A | Hall B | Hall C | |||
| 11-1 PM | The mundane to the exotic of Transfusion and Obstetrics .(a combined clinical lab expert team) | 11-1 PM | Applications of Newer Technology in Transfusion medicine | 11-1 PM | Blood donors – enhancing the donation experience |
|
11-12 noon |
The immune challenges in obstetrics | ||||
|
11-11.30 |
When alloimmunisation breaks multiple boundaries A case and panel discussion(20 mts) Current guidelines and new avenues(10 mts) |
11-11.20 AM |
Transfer of blood / products via the Pneumatic system |
11-11.20 |
Iron stores and blood donations |
|
11.30-12 noon |
When antibodies are irrational in their behaviour – a case and panel discussion (20 mts) Whats new in this space for diagnosis and management?(10 mts) |
11.20-11.40 AM |
Enhancing transfusion safety - Bedside validation & more prior to transfusions |
11.20-11.40 AM |
Interventions that reduce adverse donor reactions |
|
11.40-12 Noon |
Automation in component separation |
11.40-12 Noon |
The walking blood bank – an answer where access is challenging? |
||
| 12-1 PM | Bleeders, liver disease and more in pregnancy | 12-1 PM | Blood safety (a debate and panel discussion) | 12-1 PM | Blood donors – enhancing safety and accessibility |
|
12- 12.30 PM |
When forces combine - Liver disease and pregnancy – a case and panel discussion(20mts) Recent advances in monitoring and therapy(10mts) |
12-12.30 PM |
Watch them debate – Are NAT and pathogen reduction the answer to blood safety in our country? |
12-12.20 PM |
The rare donor registry – possibilities and challenges |
|
12.30-1PM |
The true answer to blood safety lies in………a panel discussion with current practice points |
12.20- 12.40 PM |
Rationalising policy for blood donation in the context of emerging and re emerging infection – is there a method to the madness? |
||
|
12.30-1 PM |
The nightmare of PPH – and the myriad of complexities – a case and panel discussion (20mts) Current guidelines for management and monitoring(10mts) |
12.40-1 PM |
Donor Haemovigilance –Data and impact on routine practice |
||
| 1-2 PM | LUNCH | ||||
| Hall A | Hall B | Hall C | |||
| 2-3.30 PM | Transfusion and Liver disease – newer perspectives(a combined clinical lab team) | 2-3.30 PM | Informatics and data science in Transfusion Medicine | 2-2.30 PM | Molecular applications in Tx medicine |
|
2-2.20 PM |
The clinical lab interface in the setting of liver disease – how much does it matter? – A clinician speaks |
2-2.20 PM |
Data Science in Transfusion medicine – asking the right questions |
Clinical Implications of molecular blood grouping |
|
|
2.20 -2.40 PM |
The fragile balance of coagulation test interpretation and transfusion management in liver disease |
2.20- 2.40 PM |
First Do no Harm - Role of Technology in Assuring Transfusion Safety |
Challenges of molecular blood grouping in the Indian scenario |
|
|
2.40- 3 PM |
Complexities of transfusion support in liver transplant |
2.40- 3 PM |
Medicinal Products of Human Origin – why do we need standards |
Molecular typing – impact on platelet transfusions |
|
|
3-3.30 PM |
Case discussion(2 cases) |
3-3.30 PM |
Q&A with Panel |
Case discussion (2 cases) |
|
|
3.30-4 PM |
Coffee |
||||
| 4-5 PM | Transfusion Medicine in trauma (combined clinical lab team) | 4-5 PM | Recent Advances in Blood component and apheresis therapy | 4-5 PM | Free Paper presentation |
|
4-4.20 PM |
Scoring systems & clinical indicators to assess probability of massive transfusion in trauma – A clinical viewpoint |
4-4.20 PM |
Cryopreservation of platelets- to do or not to do? |
4-5 PM |
Come and enjoy listening to recent work done in various aspects of transfusion medicine |
|
4.20-4.40 PM |
Pathogenesis of trauma induced coagulopathy and implication on blood product usage |
4.20-4.40 PM |
Can red cells be modified to meet needs of patients with rare groups? ? iPScs – the role? |
||
|
4.40-5PM |
A case of trauma – A panel discussion |
4.40- 5PM |
Apheresis what’s new in the art and science of apheresis? Rodenticide poisoning and PLEX- the story |
||
|
5 PM |
Coffee | ||||
|
6/7 PM |
Inaugural | ||||
| Day 2 | Hall A | ||||||
| 9- 11 AM | Bringing the best to the bedside: | ||||||
|
9-11 AM |
Be a part of some stimulating discussions on current advances, and their clinical impact. A wide variety of topics – from prenatal fetal blood group and platelet genotyping to topics related to transplant , technology and beyond – a session likely to widen our thoughts and interest beyond the everyday! |
||||||
| 11-11.30 AM | Coffee | ||||||
|
11.30- 12.15 PM |
Plenary 2 | ||||||
|
12.15- 1 PM |
Award Papers | ||||||
|
1-2 PM |
Lunch | ||||||
| Hall A | Hall B | Hall C | |||||
| 2-3.30 PM | 3 Minute thesis | 2-3.30 PM | Transplant immunology-choosing the best donor for renal transplant and HSCT | 2-3.30 PM | Free Paper presentation | ||
|
2-3.30 PM |
Based on a concept developed by the university of Queensland which has gone global, this offers selected participants to showcase their research and communication skills in exactly 3 minutes. Be a part of this exciting set of presentations…. Prizes to be won! |
2-2.20 PM |
HLA and anti HLA antibodies, the traditional and newer tools available in transplant settings |
2-3.30 PM |
Come and enjoy listening to recent work done in various aspects of transfusion medicine. |
||
| 2.20-3PM |
case presentations ( complex renal and stem cell transplants) with a panel discussion on best donor choice |
||||||
|
3-3.30 PM |
Suggested feasible algorithms in the Indian Context (renal – live and deceased, and stem cell – haplo) |
||||||
|
3.30-4 PM |
Coffee |
||||||
| 4- 5 PM | Recent advances in Neonatal / Paediatric Transfusion practice ( a panel discussion and an expert talk) | 4-5 PM | Complex Immunohaematology (A panel discussion) | 4-5 PM | Free paper presentation | ||
|
4- 4. 40 PM |
Complex case scenarios in the neonatal and paediatric population with a combined panel of expert clinicians and transfusion specialists |
4-5 PM |
A discussion of 3 complex cases with an exceptional panel who will weave clinical and lab parameters to enhance our understanding of IH |
4-5 PM |
Come and enjoy listening to recent work done in various aspects of transfusion medicine |
||
|
4.40-4.50 PM |
Consolidating guidelines for RBC transfusion in the paediatric population – identifying the exceptions |
||||||
|
4.50-5 PM |
Current guidelines/ algorithms for Blood component therapy in paediatrics |
||||||
|
5 PM |
A Transfusion Medicine Treasure Hunt |
||||||
|
5.30 PM |
AGBM |
||||||
| Day 3 | Hall A | Hall B | Hall C | ||||
| 8.30-9.15 AM | Quality assurance and accreditation in transfusion medicine A Panel discussion: | 8.30-10.30 AM | Why we do what we do – a Talk, A buzzer MCQ and a discussion – all rolled into one. | 8.30-10.30 AM | Quiz finals | ||
| 8.30-9.15 AM |
A panel of experts address common challenges and ways to overcome the same, as we work towards ensuring quality and obtain accreditation of our transfusion services. |
8.30-10.30 AM |
Come and be part of a whirlwind tour of topics ranging from principles of anticoagulant reversal to nitty gritty of infectious disease testing to the wide range of tests in the transplant setting and more…. An interactive rapid fire session of discussions led by experts |
8.30 – 10.30 AM |
Come watch the grand finale of the Transfusion medicine PG quiz |
||
| 9.15-10.30 AM |
Small steps lead to big journeys - Licensing and haemovigilance - Panel discussions |
||||||
|
A panel of experts will brilliantly discuss small steps which will enable a smooth licensing process and how to deal with the essentials in a world of change and constant development be it in testing, newer components or unusual adverse event reporting management and feedback |
|||||||
|
10.30-11 AM |
Coffee | ||||||
| Hall A | |||||||
|
11-12 noon |
The path ahead….. A session which has young consultants from varied settings share their opinions on the adequacy of their training as they practice as transfusion specialists, their view on strengths gained, gaps to be filled and additional training needs, and equally importantly where they see themselves going – A panel of experts will then discuss possibilities in this educational space and suggestions for further training opportunities, avenues and niche areas , be it formal or informal both in India and overseas. | ||||||
|
12-1 PM |
Valedictory function | ||||||
